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There is a quiet corner in London, not far
from the specialty shops and heavy traffic
of Oxford Street, that is the site of the
John Snow Pub. Nothing about this pub
would catch the eye of the average passer-
by. But for epidemiologists it is a mecca, a
memorial to one oftheir most famous col-
leagues. John Snow was a Londonpy
cian in the mid-i800s who becae~ a leg
end through one simple, dramaic act.
During a local cholera outbreahe made a
map showing the geographicedistribtion
of homes with cholera victims. He found
that the affected homes were all in a neigh-
borhood that drew drinking water from a
particular pump on Broad Street. Snow
removed the handle from the Broad Street
pump (near where his namesake pub now
stands), and the epidemic subsided.
In some ways, this story neatly captures
the kind of work epidemiologists do.
Patterns ofdisease in populations can pro-
vide useful clues about causes of the dis-
ease. Snow was able to prevent the spread
of cholera while knowing nothing about
the existence of a cholera bacillus. Even
though he did not understand the underly-
ing cause, Snow was able to take effective
action because the link between the pollut-
ed water source and the outbreak of dis-
eases was so direct and unambiguous.
Today's public health problems are seldom
so clear.
Most illness in the United States today
is related to chronic diseases such as cancer,
heart disease, diabetes, and diseases of
aging. Often there is a long latency
between a dangerous exposure (e.g., to
asbestos) and theatulonse of disease.
Also, multiple fao r tieontribute
to the risk of e pidem gts can
no longer relysim lvopatterns ofrdsease
oio6sr Aen increasiy oneootso
the laoatory in carrying out thei
research. This is especially true for health
studiesthat look for damage causedby
low-evelenvironmental contain.
Degenerative Neurologic Diseases
Amyotrophic lateral sclerosis (ALS), also
known as Lou Gehrig's disease, is a devas-
tating, progressive illness that leads to
paralysis and death. Freja Kamel, senior
stafffellow, is carrying out a study ofALS
as part of a program to uncover environ-
mental causes of neurologic diseases. One
goal of the ALS study is to determine
whether environmental neurotoxins such
as lead might contribute to risk ofthe dis-
ease. This is aplausible biological hypothe-
sis, but previous sties have been equivo-
ca. A person's lifetime exposure to lead
and other toxins is difficult to determine;
previous studies have relied only on ques-
tionnaires.
Kamel's study takes advantage of a
newly developed technique, X-ray fluores-
cence (XRF), to0measure lead exposure.
XRF uses extremely low levels ofradiation
to me re the lead absorbed in a person's
Gene sleuths. Jack Taylor and Theodora Devereux hunt for clues to lung tumors in the p53 gene of
uranium miners.
bone tissue over his or her lifetime. XRF
technology was developed partly with a
research project grant and small business
innovation research grants from NIEHS to
private companies. Although XRF mac-
hines are a useful research tool, there are
only a few in the world. Kamel has collab-
orated with researchers at Harvard Medical
School who operate an XRF machine.
Kamel and her colleagues will measure
Xbn lead of patients at New England
Medical Center newly diagnosed with ALS
andotfa comparison group of patients.
Higher lead levels in the ALS patients
would provide evidence that lead exposure
over a lifetime may play a role in degenera-
tivediseases ofthe central nervous system.
In addition, Kamel is storing blood
specimens for genetic testing. With the
recent advent of rapid and inexpensive
genetic analysis, epidemiologists can begin
to explore the combined effects ofgenetics
and environmental exposures in large-scale
studies. With the DNA specimens Kamel
is storing, she and her colleagues will be
able to study genes involved in repair of
neurotoxic damage, protection against free
radicals, or metabolism ofexcitotoxic neu-
rotransmitters.
Cleft Lip and Palate
There is a rapidly growing list ofgenes that
may play a role in disease susceptibility.
People inherit variant forms of genes that
control detoxification of toxic substances,
form hormone receptors, and regulate
metabolic pathways. In collaboration
between NIEHS and the National
Institute of Public Health in Norway,
Allen Wilcox, chief of the Epidemiology
Branch, is carrying out a study of genetic
susceptibility to birth defects. Wilcox and
his colleagues plan to enroll every baby
born in Norway with cleft lip or palate
over the next five years. Norway has an
unusually well-organized system of birth
registration and medical care that makes it
possible to conduct a population-based
study. When completed, this will be the
largest study of facial clefts ever carried
out. Mothers of cases and controls will be
interviewed about environmental and
occupational exposures, diet, medications,
and other factors during pregnancy. Blood
samples will be obtained from mothers and
babies. Questionnaire information on pos-
sible hazardous exposures will be combined
with assays of certain genetic alleles in
stored samples to look for evidence that
some mothers or infants may be genetically
susceptible to the effects of specific envi-
ronmental exposures.
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Cancer
There has been more work done on genes
that predispose to cancer than on genes
associated with any other group ofdiseases.
Molecular biology is useful for other areas
of cancer research as well. For instance,
molecular markers can improve the quality
of epidemiology studies by clarifying dis-
ease subgroups. By identifying homoge-
neous subgroups ofdisease, stronger associ-
ations can be found with the underlying
risk factors. Dale Sandler, chief of the
Environmental and Molecular Epidemi-
ology Section, has recently completed a
study of acute leukemia that demonstrates
this principle. Acute leukemias are a mixed
group of cancers with diverse causes.
Sander interviewed a large sample of
patients and healthy comparison persons
about their jobs, hobbies, and medical his-
tory. Leukemia patients were classified not
only according to clinically important
pathologic subtypes, but also by chromo-
some abnormalities of the blood-forming
tissues and by whether or not there was a
mutation ofthe ras oncogene. (Specific ras
gene mutations have been seen with chem-
ical exposures in animal studies.)
Results on smoking show the useful-
ness of better classification of patients.
Smoking was found to be associated in
older patients with a twofold increase in
risk for acute myeloid leukemia and a
threefold risk for acute lymphocytic
leukemia. This relation with smoking was
even stronger within certain subtypes of
leukemia, which may offer clues as to how
smoking causes the disease. For example,
Sander has found that smoking is more
common among patients with loss of part
or all of chromosome 7. Deletion of this
chromosome has previously been seen in
patients with a history ofchemotherapy for
other diseases and in patients with occupa-
tional exposure to solvents. This suggests
that the leukemogenic effect of smoking
may be due to chemicals found in cigarette
smoke (e.g., benzene).
Similarly, Sandler and her colleagues
have found that occupational exposure to
solvents is strongly related to mutation of
the ras oncogene. In this case, the occupa-
tional exposure had not been associated
with the overall risk ofleukemia.
Oncogenes and their relation to envi-
ronmental exposures are being explored by
Jack Taylor, senior clinical investigator.
There are at least two classes of genes-
oncogenes and tumor-suppressor genes-
that seem to be critical targets for environ-
mental agents in cancer initiation and pro-
gression. Taylor's strategy is to collect
tumors from people with high exposures to
known environmental carcinogens and
then to look for evidence ofdamage to spe-
cific gene sequences. Taylor has set up col-
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laborations with groups from the United
States, Norway, and Canada to collect
tumors from persons with unique expo-
sures. The majority of his work has been
on lung and bladder cancer, both ofwhich
have strong environmental determinants.
Taylor has collected bladder tumors from
persons exposed to benzidine, 1B-naphthy-
lamine, cyclophosphamide, and cigarette
smoke and is pursuing samples from per-
sons exposed to arsenic, polycyclic aromat-
ic hydrocarbons, and phenacetin. He has
collected lung tumors from persons
exposed to radon, nickel, asbestos, and cig-
arette smoke, and is planning projects to
collect tumors from people exposed to
arsenic and chromium.
Many of these samples come from
blocks of tissue preserved by pathologists
after surgery. Even specimens that are 30
years old or more, retrieved from remote
recesses ofhospital basements, can provide
ample DNA from a single microtome slice
oftissue. Using the polymerase chain reac-
tion (PCR) technique, specific genes can
be screened and sequenced. By contrasting
the pattern of mutations in tumors from
people with different exposures, the critical
chain ofevents that lead to environmental-
ly induced cancers can begin to be charac-
terized.
The epidemiologic use of laboratory
methods is not new. Today, however, the
range of laboratory tools relevant to epi-
demiology goes far beyond infectious dis-
eases. Epidemiologic projects at NIEHS
reflect the spectrum oflaboratory methods,
from measurement ofbody burden oftox-
ins to the application ofgenetic assays, that
clarify and strengthen the study ofenviron-
mental hazards and their effects on human
health.
Vision for the Future Sets
NIEHS Priorities
"At a time when expanding research
opportunities are at odds with tighter bud-
gets, priority setting is a must," says
Kenneth Olden, NIEH-S director. Two
documents will play a key role in priority
setting for NIEHS: a recently completed
document, NIEHS's Visionfor the Future,
and its companion report which provides
the basis for the Vision document, the
1992 Report ofthe Fourth Task Force for
Research Planning in Environmental
Health Sciences, Human Health and the
Environment: Some Research Needs.
The National Advisory Environmental
Health Sciences Council, a key NIEHS
advisory body ofscientists and other profes-
sionals from outside government, oversaw
the development and review ofboth reports.
The task force report was mandated by
Congress and prepared by 19 internationally
recognized science and public health profes-
sionals, co-chaired by Morton Lippmann
and Arthur Upton, the deputy director and
former director of the Institute of
Environmental Medicine, New York Uni-
versity Medical Center, respectively.
The NIEHS'sVisionfor the Futurebuilt
on the task force report and on input over
the past two years from university-based
centers and scientists in the field of envi-
ronmental health sciences, relevant scien-
tific societies, colleagues at NIH and at
other federal agencies, industry, and the
public.
Vision for the Future describes the
NIEHS mission this way:
Human health and human disease result
from three interactive elements: environ-
mental exposures, individual susceptibility
and time. The mission of the National
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